Rise Up
Introducing RISE UP, a NEW clinical study to assess pain crises & anemia in sickle cell disease
RISE UP (NCT05031780) is a phase 2/3, double-blind, randomized, placebo-controlled, multicenter clinical trial.1
This clinical study will evaluate the efficacy and safety of mitapivat in the treatment of sickle cell disease for participants 16 years of age and older.1
Reference:
1. Data on file. Agios Pharmaceuticals, Inc.